Medtronic PLC
MDT: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$485.00 | Wgbqkzz | Rntjgsg |
Though Underlying Business Remains Moaty, Potential for Expensive M&A Drives Moat Lower
Business Strategy and Outlook
Medtronic's standing as the largest pure-play medical-device maker remains a force to be reckoned with in the med-tech landscape. Pairing Medtronic's diversified product portfolio aimed at a wide range of chronic diseases with its expansive selection of products for acute care in hospitals has bolstered Medtronic's position as a key partner for its hospital customers.